eMed review
eMed is a digital health platform best known for at-home diagnostics that now runs a clinician-supported GLP-1 weight management program.
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
eMed earns a Match Score of 50/100 (grade C) and sits #438 of 497 on our board under the balanced default weighting.
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- Coverage not published
- Brand-name
- Compounded only
- Oral option
- Injectable only
- Verification
- Not independently listed
Best for: People who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.
MatchScript's take: Our #438 pick of 497 — a focused, straightforward program, scored on the same six factors as everyone else.
The factor breakdown
eMed on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Its lowest tier isn't clearly disclosed puts Budget Fit at a below-par 48 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 56 on Speed to Start.
eMed sticks to compounded injectables, for a below-par 40 on Formulary Match.
Support lands at a middling 80 — lighter, meds-first support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
Disclosure here is thinner than the top of the board give a below-par 24 on Transparency.
Pricing in context
How eMed's monthly price sits against the category median and the cheapest provider we track.
What we like
- Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
- At-home blood collection makes lab work convenient
- Clinician review and ongoing side-effect plus adherence support
- Works with CVS Caremark so eligible employees can buy through benefits
- Established digital health company with national scale
The caveats
- Distributed mainly via employers, with limited direct cash-pay access
- No public transparent monthly price for individuals
- Eligibility and subsidy depend on what the employer chooses to cover
- Best suited to workforces, not casual self-pay shoppers
Who it's for — and who should skip it
Choose eMed if people who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.
Skip it if that doesn't sound like you. A closer fit may be Actin (Match Score 50) — or take the quiz to see where eMed lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
eMed against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | eMedthis provider | CoreAge Rxour #1 | Actinclosest scorer |
|---|---|---|---|
| Sema price | Not disclosed | $149/mo | $169/mo (compounded) |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable | Injectable | Injectable |
| Match Score | 50 · C | 91 · A− | 50 · C |
eMed, answered
Is eMed legit?
eMed is a real, operating GLP-1 telehealth program, but we don't find it on the LegitScript registry, so it carries less third-party verification than the certified providers on our board. It dispenses compounded medication, which isn't FDA-approved. Vet the prescriber and pharmacy before you commit.
How much does eMed cost?
eMed doesn't publish a clear compounded-semaglutide price up front. You'll typically see full pricing after the intake questionnaire. Get the all-in monthly number in writing before you pay.
Does eMed ship to my state?
eMed operates in a limited set of states (Coverage not published). If yours isn't on that list, you'll need a nationwide provider instead.
eMed vs CoreAge Rx — which is better?
Both are on our board. eMed scores 50/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. eMed can still win for you if its strengths match your priorities — best for: People who want employees whose company offers eMed GLP-1 benefits and wants at-home labs. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified June 2026 from eMed's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on eMed's site. Not medical advice; see our disclosure.
eMed earns a Match Score of 50/100 (grade C) and sits #438 of 497 on our board under the balanced default weighting. eMed is a digital health platform best known for at-home diagnostics that now runs a clinician-supported GLP-1 weight management program. Best for: People who want employees whose company offers eMed GLP-1 benefits and wants at-home labs. If it isn't the right fit, Actin is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest eMed on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| FlyteHealth#439 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Fridays#440 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| G-Plans#441 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Ilant Health#442 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Iron Med RX#443 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Medical Health Institute#444 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Midi Health#445 | 50 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| PrescribedRX#446 | 50 | $189/mo (compounded) | $276/mo (compounded) | Coverage not published | Alternatives | Visit |
| RxION Health#447 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Vida Health#448 | 50 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Zealthy#449 | 50 | $286/mo (starting dose, plus a separate fee, compounded) | $351/mo (starting dose, plus a separate fee, compounded) | 34 states | Alternatives | Visit |
| Aspire Health#450 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Elevate Health#451 | 49 | $299/mo (compounded) | $399/mo (compounded) | Coverage not published | Alternatives | Visit |
| Enara Health#452 | 49 | Not disclosed | Not disclosed | 6 states | Alternatives | Visit |
| Evolve Telemed#453 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Garcia Weight Loss, Aesthetics & Hormone Therapy#454 | 49 | $400/mo (starting dose, compounded) | Not disclosed | 1 states | Alternatives | Visit |
| Genesis Lifestyle Medicine#455 | 49 | Not disclosed | Not disclosed | 8 states | Alternatives | Visit |
| MDExam#456 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| MultiMedRx#457 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Omzo#458 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| RegenCen#459 | 49 | Not disclosed | Not disclosed | 2 states | Alternatives | Visit |
| Royal Medical Center#460 | 49 | Not disclosed | $450/mo (2.5 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| Tablet Health#461 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Trimrose#462 | 49 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |